Prognostic value breast cancers receptor erbb 2. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Axilla Lymph Nodes Mammary Glands, Human Neoplastic Cells, Circulating Neoplastic Stem Cells Nipples Epithelial Cells

Organisms2

Mice, Nude Mice, SCID

Diseases47

Breast Neoplasms Carcinoma, Ductal, Breast Neoplasm Invasiveness Neoplasm Metastasis Breast Diseases Lymphatic Metastasis Neoplasm Recurrence, Local Breast Neoplasms, Male Carcinoma Disease Progression Lung Neoplasms Carcinoma, Lobular Ovarian Neoplasms Carcinoma, Intraductal, Noninfiltrating Genetic Predisposition to Disease Adenocarcinoma Neoplasms, Hormone-Dependent Mammary Neoplasms, Experimental Prostatic Neoplasms Stomach Neoplasms Neoplasms Bone Neoplasms Colorectal Neoplasms Carcinoma, Squamous Cell Fibrocystic Breast Disease Carcinoma, Ductal Colonic Neoplasms Neoplastic Cells, Circulating Carcinoma, Non-Small-Cell Lung Cell Transformation, Neoplastic Pancreatic Neoplasms Neovascularization, Pathologic Recurrence Carcinoma in Situ Uterine Cervical Neoplasms Urinary Bladder Neoplasms Liver Neoplasms Neoplasms, Second Primary Triple Negative Breast Neoplasms Endometrial Neoplasms Inflammatory Breast Neoplasms Brain Neoplasms Esophageal Neoplasms Rectal Neoplasms Fibroadenoma Melanoma Myocardial Infarction

Chemicals and Drugs61

Neuregulin-1 Neuregulins Receptor, erbB-3 Receptor, erbB-2 Receptor, Epidermal Growth Factor Tumor Markers, Biological Receptors, Estrogen Epidermal Growth Factor Receptors, Progesterone Tamoxifen Neoplasm Proteins Antineoplastic Agents Antineoplastic Agents, Hormonal Ki-67 Antigen RNA, Messenger Estrogen Receptor alpha DNA, Neoplasm Estrogens Tumor Suppressor Protein p53 BRCA2 Protein Biological Markers Cyclophosphamide BRCA1 Protein Fluorouracil Estrogen Antagonists Aromatase Inhibitors Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antigens, Neoplasm RNA, Small Interfering Tumor Suppressor Proteins RNA, Neoplasm Estradiol Epirubicin Estrogen Receptor Modulators Radiopharmaceuticals Proto-Oncogene Proteins Doxorubicin Nitriles Selective Estrogen Receptor Modulators Paclitaxel Mucin-1 Oncogene Proteins v-erbB MicroRNAs Transcription Factors Anthracyclines DNA-Binding Proteins Proto-Oncogene Proteins c-akt Quinazolines Cancer Vaccines Nuclear Proteins Cyclin D1 Carcinoembryonic Antigen Antigens, CD24 Cisplatin Cadherins Proto-Oncogene Proteins c-bcl-2 Methotrexate Anticarcinogenic Agents Antibiotics, Antineoplastic Triazoles

Analytical, Diagnostic and Therapeutic Techniques and Equipment82

Prognosis Survival Analysis Neoplasm Staging Predictive Value of Tests Survival Rate Disease-Free Survival Follow-Up Studies Multivariate Analysis Retrospective Studies Immunohistochemistry Risk Factors Kaplan-Meier Estimate Prospective Studies Proportional Hazards Models Mammography Treatment Outcome Chemotherapy, Adjuvant Risk Assessment Antineoplastic Combined Chemotherapy Protocols Mastectomy Gene Expression Profiling Cohort Studies Early Detection of Cancer Case-Control Studies Reverse Transcriptase Polymerase Chain Reaction Tissue Array Analysis Sensitivity and Specificity Risk Mammary Neoplasms, Experimental Neoplasm Grading Incidence Odds Ratio Breast Self-Examination Combined Modality Therapy Reproducibility of Results Immunoenzyme Techniques Blotting, Western Mastectomy, Segmental Oligonucleotide Array Sequence Analysis ROC Curve Tumor Burden Registries Logistic Models Xenograft Model Antitumor Assays Mitotic Index Polymerase Chain Reaction In Situ Hybridization, Fluorescence Chi-Square Distribution Radiotherapy, Adjuvant Neoadjuvant Therapy Transplantation, Heterologous Neoplasm Transplantation Biopsy Analysis of Variance Lymph Node Excision Confidence Intervals Ultrasonography, Mammary Questionnaires SEER Program Clinical Trials as Topic Biopsy, Needle Transfection Breast Implants Mass Screening Positron-Emission Tomography Sentinel Lymph Node Biopsy Drug Administration Schedule Exercise Test DNA Mutational Analysis Severity of Illness Index Genetic Testing Radiotherapy Molecular Targeted Therapy Tomography, X-Ray Computed Flow Cytometry Mammaplasty Probability Models, Biological Drug Screening Assays, Antitumor Regression Analysis Statistics, Nonparametric Gene Knockdown Techniques

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes47

Genes, erbB Gene Expression Regulation, Neoplastic Time Factors Genes, erbB-2 Postmenopause Genes, BRCA1 Drug Resistance, Neoplasm Sensitivity and Specificity Cell Proliferation Genetic Predisposition to Disease Risk Premenopause Breast Feeding Mutation Signal Transduction Menopause Odds Ratio Genes, BRCA2 Apoptosis Gene Amplification Cell Division Cell Movement DNA Methylation Chi-Square Distribution Down-Regulation Genotype Promoter Regions, Genetic Up-Regulation Gene Expression Polymorphism, Genetic Genes, p53 Phosphorylation Cell Growth Processes Germ-Line Mutation Transfection Cell Cycle Ploidies Phenotype RNA Interference Genes, Neoplasm Dose-Response Relationship, Drug Cell Survival Genes, Tumor Suppressor Base Sequence Gene Silencing Probability Parity

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life Survival

Humanities1

Quality of Life

Information Science7

Survival Rate Incidence Registries Questionnaires SEER Program Base Sequence Molecular Sequence Data

Named Groups2

Survivors European Continental Ancestry Group

Health Care37

Survival Analysis Predictive Value of Tests Survival Rate Disease-Free Survival Follow-Up Studies Multivariate Analysis Retrospective Studies Risk Factors Kaplan-Meier Estimate Prospective Studies Proportional Hazards Models Treatment Outcome Risk Assessment Cohort Studies Case-Control Studies Sensitivity and Specificity Age Factors Risk Incidence Odds Ratio Reproducibility of Results ROC Curve Registries Logistic Models Chi-Square Distribution Analysis of Variance Confidence Intervals Questionnaires SEER Program Clinical Trials as Topic Mass Screening Severity of Illness Index Genetic Testing Probability Regression Analysis Parity Statistics, Nonparametric

Geographicals3

United States China Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Neuregulin-1 Neuregulins Receptor, erbB-3 Receptor, erbB-2 Receptor, Epidermal Growth Factor Breast Prognosis Breast Neoplasms Tumor Markers, Biological Carcinoma, Ductal, Breast Receptors, Estrogen Survival Analysis Neoplasm Staging Epidermal Growth Factor Predictive Value of Tests Cell Line, Tumor Genes, erbB Gene Expression Regulation, Neoplastic Survival Rate Disease-Free Survival Follow-Up Studies Receptors, Progesterone Neoplasm Invasiveness Neoplasm Metastasis Multivariate Analysis Tamoxifen Breast Diseases Retrospective Studies Immunohistochemistry Risk Factors Kaplan-Meier Estimate Prospective Studies Lymphatic Metastasis Proportional Hazards Models Mammography Neoplasm Proteins Treatment Outcome Neoplasm Recurrence, Local Antineoplastic Agents Chemotherapy, Adjuvant Breast Neoplasms, Male Risk Assessment Antineoplastic Agents, Hormonal Antineoplastic Combined Chemotherapy Protocols Carcinoma Time Factors Disease Progression Mastectomy Lung Neoplasms Carcinoma, Lobular Gene Expression Profiling Cohort Studies Early Detection of Cancer Ovarian Neoplasms Ki-67 Antigen Genes, erbB-2 Postmenopause Case-Control Studies Genes, BRCA1 Reverse Transcriptase Polymerase Chain Reaction Tissue Array Analysis Drug Resistance, Neoplasm Sensitivity and Specificity Age Factors Carcinoma, Intraductal, Noninfiltrating Cell Proliferation Tumor Cells, Cultured Mice, Nude RNA, Messenger Genetic Predisposition to Disease MCF-7 Cells Adenocarcinoma Estrogen Receptor alpha Risk DNA, Neoplasm Neoplasms, Hormone-Dependent Mammary Neoplasms, Experimental Prostatic Neoplasms Premenopause Breast Feeding Estrogens Neoplasm Grading Mutation Signal Transduction Stomach Neoplasms Tumor Suppressor Protein p53 Menopause Incidence Odds Ratio Neoplasms Axilla Breast Self-Examination Lymph Nodes Combined Modality Therapy Reproducibility of Results Immunoenzyme Techniques BRCA2 Protein Biological Markers Blotting, Western Bone Neoplasms

No FAQ available that match "prognostic value breast cancers receptor erbb 2"